The main novelty of the present study is that we analyzed in a well-characterized cohort of women with MO and NAFLD the involvement of SFRP5 and the noncanonical WNT pathway in NAFLD pathogenesis. The gene discussed is SFRP5; the disease is metabolic dysfunction-associated steatotic liver disease.